CE certification of standalone software and apps seminar – the movie

Rather than streaming our last medical technology seminar on CE Certification of Standalone Software and Apps of 16 October in real time (big hassle and very prone to tech glitches we’ve found), we decided to record a video of it instead, and post that on my firm’s brand new Youtube Channel (watch that space for more video material). So here you go with three hours of exciting and action-packed presentations on

  • designing medical software for compliance;
  • qualification of standalone software as medical device;
  • the Dutch competent authorities’ plans to enforce in earnest as of 1 January 2014;
  • practical aspects of CE marking.

If you want the underlying presentations for future reference, that’s fine too. You can download them directly from my firm’s website News section without any hassle, paywall, or extortion of personal data and relentless follow-up harassment by email or telephone. We hate to do that, and are convinced that you will remember us anyway if you think the material is useful. If you want to be on our mailing list for these seminars, that’s your choice – just let us know and we’ll put you on it.

You can help of course by liking the presentation movies in YouTube so they’ll become more visible in the search results in Google and YouTube.

And there is a lot more software material on this blog, see here.


Navigate through our knowledgebase

Related articles

Article

New sort of applicable economic operators regulation: the Market Surveillance Regulation

Attentive attendees of my presentations will have remarked in my presentations about economic operators that essential parts of the general Goods Package were being amended and that this may affect companies in…

Read more

Article

Transparency vs. Confidentiality: EFSA’s new role as from March 2021

Last month, the European Council formally adopted the new Regulation on the transparency of the EU risk assessment in the food chain, which will be applicable as of 26 March 2021. As is in the name, the new provisions aim at increased transparency of EU risk assessment, which for a large deal means strengthening the […]

Article

€ 500 per data subject – a quantification of why GDPR matters

Clients often ask me why they should invest in General Data Protection Regulation (GDPR) compliance so much. For medical devices and medicines regulatory compliance, they get it to an extent. Non-compliant devices…

Read more